Twin-to-Twin Transfusion Syndrome (TTTS) is a placental complication that can affect twins who share one placenta. The key to safer care is identifying a monochorionic pregnancy early, starting close ultrasound surveillance at 16 weeks, and referring quickly to a fetal therapy center if TTTS develops. Symptoms can occur, but many cases are first found on ultrasound.
Quick Answer
TTTS cannot currently be prevented with diet, supplements, or lifestyle changes. The practical priorities are to confirm whether twins share a placenta, begin close ultrasound surveillance from 16 weeks, and refer promptly if fluid or blood-flow abnormalities appear. Stage II through IV disease between 16 and 26 weeks is generally treated with fetoscopic laser surgery.
Key Takeaways
- TTTS develops in twins or higher-order multiples that share a placenta; it is not simply a complication of every identical-twin pregnancy.
- About 10% to 15% of monochorionic twin pregnancies develop TTTS.
- Ultrasound surveillance is the main way to detect the condition before serious complications develop.
- Stage I disease may sometimes be monitored closely, while Stage II through IV disease often requires fetoscopic laser treatment.
- TTTS does not automatically require a cesarean delivery; timing and method of birth depend on the individual pregnancy.
Understanding Twin-to-Twin Transfusion Syndrome
Twin-to-Twin Transfusion Syndrome occurs when blood flows unevenly through blood-vessel connections in a placenta shared by two babies. One baby becomes the donor twin and the other the recipient twin, creating a circulation and amniotic-fluid imbalance.
The donor twin has less circulating blood volume and usually produces less urine, which can lead to too little amniotic fluid, called oligohydramnios. The recipient receives excess blood volume, produces more urine, and can develop too much amniotic fluid, called polyhydramnios.
The extra workload can place increasing stress on the recipient twin’s heart. The International Society of Ultrasound in Obstetrics and Gynecology’s TTTS guidance explains that ultrasound assessment focuses on the fluid around each twin, fetal bladders, blood flow, and signs of cardiovascular strain.
TTTS is different from twin anemia-polycythemia sequence, or TAPS. TTTS primarily produces a volume and amniotic-fluid imbalance, while TAPS involves an imbalance in red blood cells that may occur without the same marked fluid difference.
How TTTS Is Staged
Doctors commonly use the Quintero staging system to describe how far TTTS has progressed. A higher stage reflects additional ultrasound evidence of circulatory compromise, although treatment decisions also consider gestational age and the complete clinical picture.
| Stage | Main Finding |
|---|---|
| Stage I | Too little fluid around the donor and too much around the recipient. |
| Stage II | The donor twin’s bladder is no longer visible during the ultrasound examination. |
| Stage III | Doppler ultrasound shows abnormal blood-flow patterns in one or both babies. |
| Stage IV | Hydrops, or severe abnormal fluid buildup in a fetus, develops. |
| Stage V | One or both babies have died before birth. |
Who Is at Risk for TTTS?
The defining risk for TTTS is a pregnancy in which babies share one placenta, known as a monochorionic pregnancy. Family history, a particular diet, maternal behavior, and a known inherited gene have not been shown to cause TTTS.
Confirm Whether the Twins Share a Placenta
Finding out that a pregnancy contains twins is only the first step. The more important TTTS question is whether the twins are monochorionic and therefore share a placenta.
Most TTTS cases occur in monochorionic diamniotic twins, who share one placenta but have separate amniotic sacs. TTTS can also occur in other monochorionic multiple pregnancies. The Royal College of Obstetricians and Gynaecologists notes that triplet pregnancies can also be affected when babies share a placenta.
Symptoms such as severe morning sickness, rapid weight gain, or a larger abdomen can occur in multiple pregnancy, but they cannot determine whether TTTS is present. Ultrasound is needed to establish chorionicity and monitor for the condition.
Monitoring Amniotic Fluid Levels
Amniotic-fluid differences are among the most important ultrasound clues to TTTS. The donor usually has a low fluid level, while the recipient has excess fluid because the two babies are producing very different amounts of urine.
Clinicians also check whether each fetal bladder fills, assess fetal growth, and use Doppler ultrasound to study blood-flow patterns. These findings help distinguish early TTTS from more advanced disease and from other monochorionic complications.
Genetics, Family History, and Fertility Treatment
TTTS is not known to be hereditary or caused by a specific genetic mutation. The problem develops because of the arrangement and behavior of vascular connections in a shared placenta.
A 2026 Mayo Clinic clinical review states that there is no known genetic cause and no proven maternal risk factor for TTTS. It also notes that although IVF can slightly increase the rate of identical twinning, evidence has not shown a higher TTTS rate in IVF monochorionic pregnancies than in spontaneous ones.
Importance of Early Diagnosis
Early diagnosis matters because TTTS can progress between ultrasound examinations and advanced disease can threaten both babies. The safest strategy is scheduled surveillance rather than waiting for the pregnant parent to notice symptoms.
The Society for Maternal-Fetal Medicine recommends determining chorionicity and amnionicity in the first trimester. For monochorionic-diamniotic pregnancies, TTTS surveillance should begin at 16 weeks and continue at least every two weeks until delivery, with more frequent assessment when concerns arise.
Ultrasound surveillance should assess amniotic fluid on both sides of the dividing membrane and determine whether the fetal bladders are visible. Umbilical-artery Doppler evaluation is also recommended when possible.
Many people with TTTS have no obvious symptoms. However, excess amniotic fluid can sometimes cause rapid abdominal enlargement, discomfort, contractions, breathlessness, or changes in fetal movement.
Warning: Contact your maternity or fetal-medicine team promptly if you develop sudden abdominal swelling or pain, sudden breathlessness, contractions, leaking fluid, bleeding, or a noticeable change in your babies’ movements. These symptoms do not prove TTTS, but they need medical assessment.
Once TTTS is confirmed, treatment depends mainly on the stage, gestational age, maternal symptoms, and other fetal findings. SMFM recommends fetoscopic laser surgery as the standard treatment for Stage II through Stage IV TTTS presenting between 16 and 26 weeks. Selected Stage I cases may instead be monitored at least weekly if the patient has no additional concerning features.
Fetoscopic laser surgery treats the underlying problem by sealing the abnormal vascular connections between the twins. Amnioreduction can relieve pressure by removing excess amniotic fluid, but it does not correct the placental vascular connections themselves.
Regular Monitoring and Ultrasound Checks
Regular ultrasound checks are essential because TTTS can change quickly, even after an earlier reassuring scan. Surveillance is also necessary after treatment to look for recurrent TTTS, twin anemia-polycythemia sequence, abnormal growth, or other complications.
Importance of Regular Scans
A TTTS scan is more than a routine check of fetal size. Your team evaluates fluid around each baby, bladder filling, growth, and blood flow so that new signs of imbalance can be acted on promptly.
If TTTS is diagnosed, the frequency of scans usually increases. Patients who meet criteria for fetal therapy should be evaluated at a center experienced in fetoscopic treatment rather than relying only on routine twin-pregnancy follow-up.
Early Detection Benefits
Consistent monitoring allows your fetal-medicine team to identify progression before severe heart or circulatory problems develop. The schedule below reflects current SMFM guidance for common TTTS situations, although your own team may scan more often.
| Frequency of Scans | Benefits | Recommended Actions |
|---|---|---|
| At least every 2 weeks from 16 weeks | Routine TTTS surveillance in monochorionic-diamniotic twins | Continue through delivery unless more frequent monitoring is needed |
| At least weekly | Monitor asymptomatic Stage I TTTS managed without immediate laser surgery | Watch closely for progression or new maternal symptoms |
| Weekly for 6 weeks after laser | Check treatment response and detect post-laser complications | Follow the fetal therapy team’s surveillance plan |
| Every other week after the initial post-laser period | Continue surveillance when recovery is stable | Increase frequency again if TTTS, TAPS, or growth concerns arise |
Nutritional Considerations for Expecting Mothers
Good nutrition supports a twin pregnancy, but food, hydration, or supplements cannot prevent or treat TTTS. TTTS is caused by circulation through vascular connections in a shared placenta, not by a lack of water, protein, healthy fats, or a particular vitamin.
The American College of Obstetricians and Gynecologists’ multiple-pregnancy guidance notes that people carrying multiples generally need additional nutrition and appropriate weight gain compared with a singleton pregnancy. Your obstetric team can tailor those needs to your starting weight, medical history, and pregnancy course.
- Follow your prenatal vitamin plan: Take the prenatal supplement recommended by your maternity team and do not increase doses on your own.
- Choose nutrient-dense foods: Include a balanced mix of protein foods, vegetables, fruits, whole grains, and healthy fat sources as tolerated.
- Stay appropriately hydrated: Drink enough for normal pregnancy needs, but do not try to correct TTTS-related amniotic-fluid differences by greatly increasing fluid intake.
Note: Nutrition is supportive care, not a substitute for fetal-medicine surveillance or treatment. If TTTS is suspected or diagnosed, do not delay specialist assessment while trying dietary changes, supplements, bed rest, or other home measures.
Discussing Delivery Options With Healthcare Providers
TTTS does not automatically mean you will need a cesarean delivery. The safest timing and method of birth depend on fetal presentation, gestational age, growth, previous treatment, maternal health, fetal well-being, and standard obstetric considerations.
SMFM specifically advises that undergoing fetoscopic laser surgery should not, by itself, determine the mode of delivery. For pregnancies with two surviving monochorionic-diamniotic twins after TTTS has resolved following laser therapy, and with no other reason for earlier delivery, SMFM recommends delivery at 34 to 36 weeks.
Your circumstances may require a different plan, especially if there is recurrent TTTS, growth restriction, abnormal Doppler findings, membrane rupture, preterm labor, fetal compromise, or another obstetric complication.
Ask your healthcare team about the expected timing of delivery, whether vaginal birth is reasonable in your case, what findings would change the plan, and whether the hospital has the neonatal services your babies may need after birth.
Emotional Support and Counseling
A TTTS diagnosis can create intense uncertainty because decisions about surveillance, fetal therapy, and delivery may need to be made quickly. Emotional support is therefore part of good high-risk pregnancy care, not an optional extra.
- Talk openly with your care team. Ask them to explain the TTTS stage, treatment choices, likely next steps, and what changes would require urgent action.
- Consider professional counseling. A therapist experienced in high-risk pregnancy, pregnancy loss, trauma, or neonatal intensive care can help with anxiety and difficult decisions.
- Keep trusted people informed. A partner, relative, or friend can attend appointments, take notes, and help you remember questions during stressful consultations.
- Use peer support carefully. Other TTTS families can provide emotional understanding, but individual medical decisions should still come from your fetal-medicine team.
Resources for Families Facing TTTS
The most important medical resource after a TTTS diagnosis is a maternal-fetal medicine or fetal intervention center with experience treating monochorionic complications. SMFM recommends referral to a fetal intervention center when a patient qualifies for laser therapy.
For non-medical education and peer support, the Twin to Twin Transfusion Syndrome Foundation provides family resources, support groups, and information for parents during pregnancy and after birth. Support organizations can be valuable emotionally, but they should complement rather than replace your specialist team’s advice.
Long-term follow-up can also matter after delivery. A systematic review and meta-analysis of 1,499 laser-treated TTTS survivors reported neurodevelopmental impairment in about 14%, with higher risk associated with earlier delivery and lower birth weight. This does not mean an individual child will have developmental problems, but it supports discussing developmental follow-up with the pediatric team.
Depending on how the pregnancy and newborn period progress, follow-up may involve neonatology, pediatric cardiology, developmental specialists, physical or occupational therapy, or other services. Ask before discharge what monitoring each baby needs and which appointments should already be scheduled.
Frequently Asked Questions
Can TTTS Occur in Pregnancies With More Than Two Fetuses?
Yes. TTTS can occur in triplet or higher-order pregnancies when two or more babies share a monochorionic placenta. The exact monitoring and treatment plan is more complex than for a twin pregnancy and should be individualized by a fetal-medicine specialist.
What Are the Long-Term Effects of TTTS on Surviving Twins?
Many TTTS survivors develop well, but the condition can increase the risk of neurodevelopmental problems and complications related to premature birth. The individual outlook depends on factors such as gestational age at delivery, birth weight, brain injury, cardiac effects, and the overall course of the pregnancy.
Is There a Genetic Component Associated With TTTS?
No specific genetic cause of TTTS is currently known. The condition develops because twins share a placenta containing vascular connections that allow an unbalanced net transfer of blood, rather than because of a known inherited TTTS gene.
Are There Any Alternative Therapies for Managing TTTS?
No alternative therapy has been established as a treatment for the abnormal placental blood-vessel connections that cause TTTS. Acupuncture, herbal remedies, supplements, dietary changes, or bed rest should not replace specialist monitoring or recommended fetal treatment, and pregnancy supplements or herbs should be discussed with your clinician first.
How Can Families Cope With the Emotional Impact of TTTS?
Families can cope by getting clear information from the fetal-medicine team, involving trusted relatives or friends, and seeking counseling or peer support. It can also help to write down questions before appointments and ask the medical team to explain the plan again whenever decisions feel overwhelming.
Can Twin-to-Twin Transfusion Syndrome Be Prevented?
There is currently no proven way to prevent TTTS. Because the condition arises from blood-vessel connections in a shared placenta, the most effective strategy is early identification of monochorionic twins and regular ultrasound surveillance so changes can be detected and treated promptly.
What Symptoms of TTTS Should Prompt an Urgent Call?
Many cases cause no noticeable maternal symptoms, but sudden abdominal swelling or pain, breathlessness, contractions, leaking fluid, bleeding, or a change in fetal movement should prompt medical assessment. Symptoms alone cannot diagnose TTTS, so scheduled ultrasound surveillance remains essential even when you feel well.
Sources
- Society for Maternal-Fetal Medicine Consult Series #72: TTTS screening, surveillance, laser treatment, post-treatment monitoring, and delivery guidance.
- International Society of Ultrasound in Obstetrics and Gynecology: TTTS symptoms, ultrasound diagnosis, staging, and treatment overview.
- Mayo Clinic: TTTS cause, staging, risk-factor evidence, surveillance, and fetoscopic laser treatment.
- Royal College of Obstetricians and Gynaecologists: monochorionic pregnancy monitoring, TTTS in twin and triplet pregnancies, and warning symptoms.
- American College of Obstetricians and Gynecologists: nutrition, weight gain, and antenatal considerations in multiple pregnancy.
- PubMed: systematic review and meta-analysis of neurodevelopment after TTTS laser treatment: long-term neurodevelopmental outcomes and associated perinatal risk factors.
- Twin to Twin Transfusion Syndrome Foundation: educational and peer-support resources for families before and after TTTS treatment.
